Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This Phase 2, double-blind, randomized, placebo-controlled, multicenter study, with an open-label long-term safety extension (LTSE), will evaluate the effect of Obeticholic Acid, and the subsequent addition of statin therapy, on lipoprotein metabolism in subjects with nonalcoholic steatohepatitis (NASH) with fibrosis stage 1 to 4, but no evidence of hepatic decompensation.
Epistemonikos ID: fe80ba8dfbab2c6fa1515740b1eb8b45ef557189
First added on: May 12, 2024